{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:35:29Z","timestamp":1786995329817,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.oret.2020.12.020","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T01:20:08Z","timestamp":1609464008000},"page":"975-980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["The Effect of Delay in Care among Patients Requiring Intravitreal Injections"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1116-1371","authenticated-orcid":false,"given":"Weilin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra V.","family":"Rachitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2020.12.020_bib1","first-page":"CD011230","article-title":"Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration","volume":"9","author":"Moja","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.oret.2020.12.020_bib2","first-page":"CD011346","article-title":"Aflibercept for neovascular age-related macular degeneration","volume":"2","author":"Sarwar","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.oret.2020.12.020_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/IAE.0000000000002253","article-title":"Aflibercept for persistent diabetic macular edema: forty-eight-week outcomes.","volume":"39","author":"Bahrami","year":"2019","journal-title":"Retina (Phila)"},{"key":"10.1016\/j.oret.2020.12.020_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.12.020_bib5","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2010.08.016","article-title":"Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study","volume":"117","author":"Nguyen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.12.020_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ophtha.2015.09.035","article-title":"Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study","volume":"123","author":"Clark","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.12.020_bib7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/bjophthalmol-2014-306543","article-title":"A\u00a0randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL report no. 1","volume":"99","author":"Narayanan","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2020.12.020_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","article-title":"Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration","volume":"99","author":"Holz","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2020.12.020_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2147\/OPTH.S128509","article-title":"Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO study report 1)","volume":"11","author":"Blinder","year":"2017","journal-title":"Clinical Ophthalmology (Auckland, NZ)"},{"key":"10.1016\/j.oret.2020.12.020_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2147\/OPTH.S163859","article-title":"Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)","volume":"12","author":"Jumper","year":"2018","journal-title":"Clinical Ophthalmology (Auckland, NZ)"},{"key":"10.1016\/j.oret.2020.12.020_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/OPTH.S151611","article-title":"Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients","volume":"12","author":"Ehlken","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2020.12.020_bib12","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/IAE.0000000000001892","article-title":"Compliance and adherence of patients with diabetic macular edema to intravitreal anti-vascular endothelial growth factor therapy in daily practice","volume":"38","author":"Weiss","year":"2018","journal-title":"Retina (Phila)"},{"key":"10.1016\/j.oret.2020.12.020_bib13","article-title":"Consequences of lapses in treatment with vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration in routine clinical practice","author":"Greenlee","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.oret.2020.12.020_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jfo.2014.11.015","article-title":"Ranibizumab for exudative age-related macular degeneration: a five year study of adherence to follow-up in a real-life setting","volume":"38","author":"Boulanger-Scemama","year":"2015","journal-title":"J\u00a0Fr Ophtalmol"},{"key":"10.1016\/j.oret.2020.12.020_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ophtha.2020.03.037","article-title":"Preparedness among ophthalmologists: during and beyond the COVID-19 pandemic","volume":"127","author":"Olivia Li","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.12.020_bib18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/IAE.0b013e3181d87e04","article-title":"Novel method for analyzing Snellen visual acuity measurements","volume":"30","author":"Gregori","year":"2010","journal-title":"Retina (Phila)"},{"key":"10.1016\/j.oret.2020.12.020_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1370\/afm.949","article-title":"Ambulatory care provided by office-based specialists in the United States","volume":"7","author":"Valderas","year":"2009","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.oret.2020.12.020_bib20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3928\/23258160-20201202-02","article-title":"Characterization of kiosk usage for ophthalmic outpatient visits","volume":"51","author":"Song","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2020.12.020_bib21","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2020.12.020_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajo.2020.06.040","article-title":"The short-term effect of a single lapse in anti-vascular endothelial growth factor treatment for diabetic macular edema within routine clinical practice","volume":"219","author":"Yalamanchili","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.12.020_bib23","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2147\/OPTH.S256009","article-title":"Correlation of baseline visual acuity with outcomes of treatment with anti-VEGF in neovascular age-related macular degeneration","volume":"14","author":"Veluswamy","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2020.12.020_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.oret.2017.10.003","article-title":"Baseline predictors for five-year visual acuity outcomes in the comparison of AMD treatment trials","volume":"2","author":"Ying","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2020.12.020_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1547-5069.2003.tb00001.x","article-title":"Adherence to long-term therapies: evidence for action","volume":"35","author":"Burkhart","year":"2003","journal-title":"J\u00a0Nurs Scholarsh"},{"key":"10.1016\/j.oret.2020.12.020_bib26","first-page":"JE01","article-title":"How can doctors improve their communication skills?","volume":"9","author":"Ranjan","year":"2015","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.oret.2020.12.020_bib27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5694\/j.1326-5377.2005.tb07085.x","article-title":"Use of SMS text messaging to improve outpatient attendance","volume":"183","author":"Downer","year":"2005","journal-title":"Med J Aust"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020305078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020305078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:30:05Z","timestamp":1762853405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653020305078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2468653020305078"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2020.12.020","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Delay in Care among Patients Requiring Intravitreal Injections","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2020.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}